Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Oregon, captioned Truedson v. NuScale Power Corporation, et al., No. 3:26-cv-00328 [3]. - Investors have until April 20, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - NuScale Power Corporation specializes in nuclear technology, particularly the NuScale Power Module (NPM), a small modular nuclear reactor designed for energy generation [4]. - The company had established a partnership with ENTRA1 Energy LLC, which was responsible for constructing power generation facilities using NuScale's NPMs [4]. Group 3: Allegations Against ENTRA1 - NuScale allegedly misrepresented ENTRA1's capabilities, claiming it had extensive experience in developing power plants, while in reality, ENTRA1 had never built or operated any significant projects [5][6]. - ENTRA1 was primarily organized to support the activities of its principal, Wadie Habboush, rather than to undertake substantial projects [6]. Group 4: Stock Price Impact - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses from $17 million in the prior year to $519 million in 3Q 2025, largely due to a $495 million payment to ENTRA1 [7]. - Following the disclosure of ENTRA1's lack of experience in nuclear power projects, NuScale's stock price fell by $4.03 per share, a decline of over 12.4%, from $32.46 on November 6, 2025, to $28.43 on November 10, 2025 [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter due to "hindsight evaluations of historical collection trends" and increased its professional liability reserves by $54 million [5]. - Following this announcement, Ardent Health's stock price fell by $4.75 per share, a decline of over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of New York, captioned Ortolani v. Plug Power Inc., et al., No. 1:26-cv-00165 [3]. - Investors have until April 3, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Plug Power securities [3]. Group 2: Company Background - Plug Power provides hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets and develops infrastructure such as hydrogen production plants [4]. - The company announced a "closed a $1.66 billion loan guarantee" from the U.S. Department of Energy to finance the construction of hydrogen production projects [4]. Group 3: Stock Performance and Events - On October 7, 2025, Plug Power's stock dropped by $0.26 per share (6.3%) following the abrupt departure of its CEO and President, from $4.13 to $3.87 [5]. - On November 10, 2025, the company announced the suspension of activities under the DOE loan program, leading to a stock drop of $0.09 per share (3.4%), from $2.65 to $2.56 [6]. - A report on November 13, 2025, confirmed the suspension of plans to construct hydrogen production facilities, resulting in a stock drop of $0.48 per share (17.6%), from $2.49 to $2.25 [7].

Core Viewpoint - Ralliant Corporation is under investigation for potential violations of federal securities laws, particularly regarding the timing and disclosure of financial information related to a significant goodwill impairment and reduced earnings guidance [1][6]. Financial Performance and Guidance - On January 30, 2026, Ralliant announced a $1.4 billion goodwill impairment and lowered its FY 2026 earnings guidance to a range of $2.22 to $2.42 per share, which was below analyst consensus expectations [2][3]. - The guidance indicated that factors such as declining demand and competitive pressures would negatively impact performance beyond the fourth quarter, raising concerns about the company's financial health [3][4]. Dividend Declaration - Just five days prior to the impairment announcement, Ralliant's board declared a quarterly dividend of $0.05 per share, which is typically seen as a sign of financial stability and management confidence [2]. - The decision to declare a dividend amidst a significant loss has led to questions regarding the board's assessment of the company's financial position at that time [2][6]. Institutional Trading Activity - STRS Ohio significantly reduced its stake in Ralliant by 95.6%, involving approximately 58,434 shares, just days before the earnings release, which has drawn scrutiny regarding the timing of trading decisions [5]. - The timing of this liquidation raises questions about whether institutional investors had prior knowledge of the company's deteriorating outlook [5]. Investigation Focus - The investigation will assess whether Ralliant and its executives disclosed all material facts about the company's outlook in a timely manner and whether their forward-looking statements were consistent with their knowledge at the time [6].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Kyndryl Holdings, Inc. for alleged material misstatements and omissions regarding its financial reporting and internal controls during the specified class period from August 7, 2024, to February 9, 2026 [2][4][6]. Summary by Relevant Sections Lawsuit Details - The lawsuit is filed in the United States District Court for the Eastern District of New York, under the case caption Brander v. Kyndryl Holdings, Inc., et al, Case No. 1:26-cv-00782 (E.D.N.Y.) [2][4]. - Investors have until April 13, 2026, to file for lead plaintiff status [2][6]. Allegations - The complaint alleges that Kyndryl's financial statements during the class period were materially misstated [4]. - It is claimed that Kyndryl lacked adequate internal controls and materially understated issues related to these controls [4]. - The company is accused of being unable to timely file its quarterly report on Form 10-Q for the quarter ended December 31, 2025, due to these issues [4]. Investor Actions - Kyndryl investors can seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel by the April 13, 2026 deadline [5][6]. - Investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation regarding their legal rights and recovery options [3][6].

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in significant stock price declines [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Diez v. Richtech Robotics Inc., and it involves purchasers of Richtech Robotics securities from January 27, 2026, to January 29, 2026 [1]. - Investors have until April 3, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period [3]. Group 2: Impact of Allegations - On January 29, 2026, an article by Hunterbrook Media stated that Microsoft denied any partnership with Richtech Robotics, leading to a more than 29% drop in the price of Richtech Robotics Class B stock over two trading days [4]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is representing investors in this class action lawsuit and is recognized as a leading law firm in securities fraud litigation [6]. - The firm has a strong track record, recovering over $916 million for investors in 2025 alone and $8.4 billion over the past five years [6].

Group 1 - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to Black Hills Corp.'s merger with NorthWestern Energy Group, where Black Hills shareholders will own approximately 56% of the combined company upon completion [2] - Clearwater Analytics Holdings, Inc. is being sold to Permira and Warburg Pincus for $24.55 per share in cash, while European Wax Center, Inc. is being sold to General Atlantic for $5.80 per share in cash [3] - Halper Sadeh LLC may seek increased consideration, additional disclosures, and other relief on behalf of shareholders [4]

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed by Bleichmar Fonti & Auld LLP and is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a 180-day cliff method for reserving accounts [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and its senior executives for securities fraud, following significant stock price drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Plug Power specializes in hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets, and it develops infrastructure such as hydrogen production plants [4]. Legal Proceedings - Investors have until April 3, 2026, to request to lead the case in the U.S. District Court for the Northern District of New York, under the case caption Ortolani v. Plug Power Inc., et al. [3]. Allegations - The lawsuit claims that Plug Power materially overstated the likelihood of receiving a $1.66 billion loan guarantee from the U.S. Department of Energy, which was intended to finance the construction of hydrogen production facilities [4]. Stock Price Impact - On October 7, 2025, Plug Power's stock dropped by $0.26 (6.3%) following the announcement of the abrupt departure of its CEO and President [5]. - On November 10, 2025, the stock fell by $0.09 (3.4%) after the company suspended activities under the DOE loan program [6]. - On November 14, 2025, the stock further declined by $0.48 (17.6%) after reports confirmed the suspension of plans to construct hydrogen production facilities, jeopardizing the $1.66 billion DOE loan [7].

Core Viewpoint - A class action lawsuit has been filed against CoreWeave, Inc. and its senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - CoreWeave is an AI-focused cloud computing company that operates data centers providing high-performance GPU infrastructure. The company relies on partnerships, including a merger agreement with Core Scientific announced on July 7, 2025 [4]. Allegations of Securities Fraud - The lawsuit claims that CoreWeave misrepresented its ability to meet customer demand and concealed significant construction delays at its data centers, despite assurances of being able to capitalize on unprecedented demand [5]. Stock Performance and Impact - On October 30, 2025, CoreWeave's stock dropped by $8.87 (over 6%) after Core Scientific failed to secure enough shareholder votes for the merger, leading to the termination of the agreement [6]. - Following a revenue guidance cut on November 10, 2025, due to delays from a third-party developer, CoreWeave's stock fell by $17.22 (over 16%) [7]. - Additional delays reported on December 15, 2025, regarding a major data center in Texas led to a further stock decline of $2.85 (over 3%) [8].